Beyond expectations: Novel insights into epidermal keratin function and regulation

International Review of Cell and Molecular Biology

Volumn 311, Issue , 2014, Pages 265-306

  Homberg, Melanie ^a   Magin, Thomas M ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Cell migration; Desmosomes; EBS; Epidermal barrier; Epidermis; Inflammation; Intermediate filaments; Keratins

Indexed keywords

INVOLUCRIN; KERATIN; PROTEIN P63; TRANSCRIPTION FACTOR NRF2; PROTEIN BINDING;

ARTICLE; BASEMENT MEMBRANE; BINDING SITE; BLISTER; CARCINOGENESIS; CELL ADHESION; CELL DIFFERENTIATION; CELL FUNCTION; CELL GROWTH; CELL INVASION; CELL PROLIFERATION; CELL STRUCTURE; CELLULAR STRESS RESPONSE; CYTOARCHITECTURE; CYTOSKELETON; DESMOSOME; DOWN REGULATION; EPIDERMIS; EPIDERMOLYSIS BULLOSA SIMPLEX; EPITHELIUM CELL; EXTRACELLULAR MATRIX; GENE CLUSTER; GENE MUTATION; GLYCOSYLATION; HEMIDESMOSOME; HUMAN; IN VIVO STUDY; INFLAMMATION; KERATINOCYTE; KERATODERMA; MISSENSE MUTATION; MORPHOGENESIS; NONHUMAN; OXIDATIVE STRESS; PHOTOSENSITIVITY; POIKILODERMA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; SIGNAL TRANSDUCTION; SKIN ATROPHY; SKIN DISEASE; SKIN FRAGILITY; SUMOYLATION; UBIQUITINATION; WOUND HEALING; ANIMAL; ANTIBODY SPECIFICITY; CHEMISTRY; DISEASES; GENETICS; METABOLISM;

ANIMALS; DISEASE; EPIDERMIS; HUMANS; KERATINS; ORGAN SPECIFICITY; PROTEIN BINDING; PROTEIN PROCESSING, POST-TRANSLATIONAL;

EID: 84902466914     PISSN: 19376448     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-800179-0.00007-6     Document Type: Chapter

References (209)

1. Akiyama M., Tsuji-Abe Y., Yanagihara M., Nakajima K., Kodama H., Yaosaka M., Abe M., Sawamura D., Shimizu H. Ichthyosis bullosa of Siemens: its correct diagnosis facilitated by molecular genetic testing. Br. J. Dermatol. 2005, 152:1353-1356.
2. Amagai M., Stanley J.R. Desmoglein as a target in skin disease and beyond. J. Investig. Dermatol. 2012, 132:776-784.
3. Andra K., Lassmann H., Bittner R., Shorny S., Fassler R., Propst F., Wiche G. Targeted inactivation of plectin reveals essential function in maintaining the integrity of skin, muscle, and heart cytoarchitecture. Genes Dev. 1997, 11:3143-3156.
4. Atkinson S.D., McGilligan V.E., Liao H., Szeverenyi I., Smith F.J., Moore C.B., McLean W.H. Development of allele-specific therapeutic siRNA for keratin 5 mutations in epidermolysis bullosa simplex. J. Investig. Dermatol. 2011, 131:2079-2086.
5. Ausch C., Buxhofer-Ausch V., Olszewski U., Hinterberger W., Ogris E., Schiessel R., Hamilton G. Caspase-cleaved cytokeratin 18 fragment (M30) as marker of postoperative residual tumor load in colon cancer patients. Eur. J. Surg. Oncol. 2009, 35:1164-1168.
6. Bader B.L., Magin T.M., Hatzfeld M., Franke W.W. Amino acid sequence and gene organization of cytokeratin no. 19, an exceptional tail-less intermediate filament protein. EMBO J. 1986, 5:1865-1875.
7. Bar J., Kumar V., Roth W., Schwarz N., Richter M., Leube R.E., Magin T.M. Skin fragility and impaired desmosomal adhesion in mice lacking all keratins. J. Investig. Dermatol. 2014, 134(4):1012-1022.
8. Beguin P.C., Gosselin H., Mamarbachi M., Calderone A. Nestin expression is lost in ventricular fibroblasts during postnatal development of the rat heart and re-expressed in scar myofibroblasts. J. Cell. Physiol. 2012, 227:813-820.
9. Bektas M., Jolly P.S., Berkowitz P., Amagai M., Rubenstein D.S. A pathophysiologic role for epidermal growth factor receptor in pemphigus acantholysis. J. Biol. Chem. 2013, 288:9447-9456.
10. Bolling M.C., Lemmink H.H., Jansen G.H., Jonkman M.F. Mutations in KRT5 and KRT14 cause epidermolysis bullosa simplex in 75% of the patients. Br. J. Dermatol. 2011, 164:637-644.
11. Bolling M.C., Jongbloed J.D., Boven L.G., Diercks G.F., Smith F.J., McLean W.H., Jonkman M.F. Plectin mutations underlie epidermolysis bullosa simplex in 8% of patients. J. Investig. Dermatol. 2014, 134:273-276.
12. Bonifas J.M., Rothman A.L., Epstein E.H. Epidermolysis bullosa simplex: evidence in two families for keratin gene abnormalities. Science (New York) 1991, 254:1202-1205.
13. Bonne G., Quijano-Roy S. Emery-Dreifuss muscular dystrophy, laminopathies, and other nuclear envelopathies. Handb. Clin. Neurol. 2013, 113:1367-1376.
14. Bose A., Teh M.T., Mackenzie I.C., Waseem A. Keratin K15 as a biomarker of epidermal stem cells. Int. J. Mol. Sci. 2013, 14:19385-19398.
15. Bouameur J.E., Schneider Y., Begre N., Hobbs R.P., Lingasamy P., Fontao L., Green K.J., Favre B., Borradori L. Phosphorylation of serine 4642 in the C-terminus of plectin by MNK2 and PKA modulates its interaction with intermediate filaments. J. Cell Sci. 2013, 126:4195-4207.
16. Bruckner-Tuderman L., Has C. Molecular heterogeneity of blistering disorders: the paradigm of epidermolysis bullosa. J. Investig. Dermatol. 2012, 132:E2-E5.
17. Candi E., Tarcsa E., Digiovanna J.J., Compton J.G., Elias P.M., Marekov L.N., Steinert P.M. A highly conserved lysine residue on the head domain of type II keratins is essential for the attachment of keratin intermediate filaments to the cornified cell envelope through isopeptide crosslinking by transglutaminases. Proc. Natl. Acad. Sci. U.S.A 1998, 95:2067-2072.
18. Candi E., Schmidt R., Melino G. The cornified envelope: a model of cell death in the skin. Nat. Rev. Mol. Cell Biol. 2005, 6:328-340.
19. Candi E., Rufini A., Terrinoni A., Dinsdale D., Ranalli M., Paradisi A., De Laurenzi V., Spagnoli L.G., Catani M.V., Ramadan S., Knight R.A., Melino G. Differential roles of p63 isoforms in epidermal development: selective genetic complementation in p63 null mice. Cell Death Differ. 2006, 13:1037-1047.
20. Cao T., Longley M.A., Wang X.J., Roop D.R. An inducible mouse model for epidermolysis bullosa simplex: implications for gene therapy. J. Cell Biol. 2001, 152:651-656.
21. Chamcheu J.C., Siddiqui I.A., Syed D.N., Adhami V.M., Liovic M., Mukhtar H. Keratin gene mutations in disorders of human skin and its appendages. Arch. Biochem. Biophys. 2011, 508:123-137.
22. Chen J., Cheng X., Merched-Sauvage M., Caulin C., Roop D.R., Koch P.J. An unexpected role for keratin 10 end domains in susceptibility to skin cancer. J. Cell Sci. 2006, 119:5067-5076.
23. Cheung K.J., Gabrielson E., Werb Z., Ewald A.J. Collective invasion in breast cancer requires a conserved Basal epithelial program. Cell 2013, 155:1639-1651.
24. Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C., Olsen J.V., Mann M. Lysine acetylation targets protein complexes and co-regulates major cellular functions. Science (New York) 2009, 325:834-840.
25. Chung B.M., Rotty J.D., Coulombe P.A. Networking galore: intermediate filaments and cell migration. Curr. Opin. Cell Biol. 2013, 25:600-612.
26. Clarke W.T., Edwards B., McCullagh K.J., Kemp M.W., Moorwood C., Sherman D.L., Burgess M., Davies K.E. Syncoilin modulates peripherin filament networks and is necessary for large-calibre motor neurons. J. Cell Sci. 2010, 123:2543-2552.
27. Clausen B.E., Kel J.M. Langerhans cells: critical regulators of skin immunity?. Immunol. Cell Biol. 2010, 88:351-360.
28. Corden L.D., McLean W.H. Human keratin diseases: hereditary fragility of specific epithelial tissues. Exp. Dermatol. 1996, 5:297-307.
29. Cotsarelis G. Epithelial stem cells: a folliculocentric view. J. Investig. Dermatol. 2006, 126:1459-1468.
30. Coulombe P.A., Fuchs E. Elucidating the early stages of keratin filament assembly. J. Cell Biol. 1990, 111:153-169.
31. Coulombe P.A., Lee C.H. Defining keratin protein function in skin epithelia: epidermolysis bullosa simplex and its aftermath. J. Investig. Dermatol. 2012, 132:763-775.
32. Coulombe P.A., Hutton M.E., Letai A., Hebert A., Paller A.S., Fuchs E. Point mutations in human keratin 14 genes of epidermolysis bullosa simplex patients: genetic and functional analyses. Cell 1991, 66:1301-1311.
33. Coulombe P.A., Kerns M.L., Fuchs E. Epidermolysis bullosa simplex: a paradigm for disorders of tissue fragility. J. Clin. Invest. 2009, 119:1784-1793.
34. D'Alessandro M., Morley S.M., Ogden P.H., Liovic M., Porter R.M., Lane E.B. Functional improvement of mutant keratin cells on addition of desmin: an alternative approach to gene therapy for dominant diseases. Gene Ther. 2004, 11:1290-1295.
35. D'Alessandro M., Coats S.E., Jonkmann M.F., Leigh I.M., Lane E.B. Keratin 14-null cells as a model to test the efficacy of gene therapy approaches in epithelial cells. J. Investig. Dermatol. 2011, 131:1412-1419.
36. De Berker D., Wojnarowska F., Sviland L., Westgate G.E., Dawber R.P., Leigh I.M. Keratin expression in the normal nail unit: markers of regional differentiation. Br. J. Dermatol. 2000, 142:89-96.
37. Delva E., Tucker D.K., Kowalczyk A.P. The desmosome. Cold Spring Harb. Perspect. Biol. 2009, 1:a002543.
38. Depianto D., Kerns M.L., Dlugosz A.A., Coulombe P.A. Keratin 17 promotes epithelial proliferation and tumor growth by polarizing the immune response in skin. Nat. Genet. 2010, 42:910-914.
39. Djian P., Easley K., Green H. Targeted ablation of the murine involucrin gene. J. Cell Biol. 2000, 151:381-388.
40. Drake P.J., Griffiths G.J., Shaw L., Benson R.P., Corfe B.M. Application of high-content analysis to the study of post-translational modifications of the cytoskeleton. J. Proteome Res. 2009, 8:28-34.
41. Favre B., Schneider Y., Lingasamy P., Bouameur J.E., Begre N., Gontier Y., Steiner-Champliaud M.F., Frias M.A., Borradori L., Fontao L. Plectin interacts with the rod domain of type III intermediate filament proteins desmin and vimentin. Eur. J. Cell Biol. 2011, 90:390-400.
42. Fine J.D. Inherited epidermolysis bullosa: past, present, and future. Ann. N. Y. Acad. Sci. 2010, 1194:213-222.
43. Fine J.D., Eady R.A., Bauer E.A., Bauer J.W., Bruckner-Tuderman L., Heagerty A., Hintner H., Hovnanian A., Jonkman M.F., Leigh I., McGrath J.A., Mellerio J.E., Murrell D.F., Shimizu H., Uitto J., Vahlquist A., Woodley D., Zambruno G. The classification of inherited epidermolysis bullosa (EB): report of the third International consensus meeting on diagnosis and classification of EB. J. Am. Acad. Dermatol. 2008, 58:931-950.
44. Fontao L., Favre B., Riou S., Geerts D., Jaunin F., Saurat J.H., Green K.J., Sonnenberg A., Borradori L. Interaction of the bullous pemphigoid antigen 1 (BP230) and desmoplakin with intermediate filaments is mediated by distinct sequences within their COOH terminus. Mol. Biol. Cell 2003, 14:1978-1992.
45. Fu D.J., Thomson C., Lunny D.P., Dopping-Hepenstal P.J., McGrath J.A., Smith F.J., Irwin McLean W.H., Pedrioli D.M. Keratin 9 is required for the structural integrity and terminal differentiation of the palmoplantar epidermis. J. Investig. Dermatol. 2014, 134(3):754-763.
46. Fuchs E., Green H. Changes in keratin gene expression during terminal differentiation of the keratinocyte. Cell 1980, 19:1033-1042.
47. Fuchs E., Weber K. Intermediate filaments: structure, dynamics, function, and disease. Annu. Rev. Biochem. 1994, 63:345-382.
48. Gallicano G.I., Kouklis P., Bauer C., Yin M., Vasioukhin V., Degenstein L., Fuchs E. Desmoplakin is required early in development for assembly of desmosomes and cytoskeletal linkage. J. Cell Biol. 1998, 143:2009-2022.
49. Goldman R.D., Cleland M.M., Murthy S.N., Mahammad S., Kuczmarski E.R. Inroads into the structure and function of intermediate filament networks. J. Struct. Biol. 2012, 177:14-23.
50. Goldstein J., Horsley V. Home sweet home: skin stem cell niches. Cell. Mol. Life Sci. 2012, 69:2573-2582.
51. Green K.J., Simpson C.L. Desmosomes: new perspectives on a classic. J. Investig. Dermatol. 2007, 127:2499-2515.
52. Hanukoglu I., Fuchs E. The cDNA sequence of a Type II cytoskeletal keratin reveals constant and variable structural domains among keratins. Cell 1983, 33:915-924.
53. Has C., Castiglia D., del Rio M., Diez M.G., Piccinni E., Kiritsi D., Kohlhase J., Itin P., Martin L., Fischer J., Zambruno G., Bruckner-Tuderman L. Kindler syndrome: extension of FERMT1 mutational spectrum and natural history. Hum. Mutat. 2011, 32:1204-1212.
54. Has C., Kiritsi D., Mellerio J.E., Franzke C.W., Wedgeworth E., Tantcheva-Poor I., Kernland-Lang K., Itin P., Simpson M.A., Dopping-Hepenstal P.J., Fujimoto W., McGrath J.A., Bruckner-Tuderman L. The missense mutation p.R1303Q in type XVII collagen underlies junctional epidermolysis bullosa resembling kindler syndrome. J. Investig. Dermatol. 2014, 134(3):845-849.
55. Hatzfeld M., Burba M. Function of type I and type II keratin head domains: their role in dimer, tetramer and filament formation. J. Cell Sci. 1994, 107(Pt. 7):1959-1972.
56. Hatzfeld M., Franke W.W. Pair formation and promiscuity of cytokeratins: formation in vitro of heterotypic complexes and intermediate-sized filaments by homologous and heterologous recombinations of purified polypeptides. J. Cell Biol. 1985, 101:1826-1841.
57. Hatzfeld M., Weber K. The coiled coil of in vitro assembled keratin filaments is a heterodimer of type I and II keratins: use of site-specific mutagenesis and recombinant protein expression. J. Cell Biol. 1990, 110:1199-1210.
58. Hatzfeld M., Wolf A., Keil R. Plakophilins in desmosomal adhesion and signaling. Cell Commun. Adhes. 2014, 21:25-42.
59. Herrmann H., Aebi U. Intermediate filaments and their associates: multi-talented structural elements specifying cytoarchitecture and cytodynamics. Curr. Opin. Cell Biol. 2000, 12:79-90.
60. Herrmann H., Hesse M., Reichenzeller M., Aebi U., Magin T.M. Functional complexity of intermediate filament cytoskeletons: from structure to assembly to gene ablation. Int. Rev. Cytol. 2003, 223:83-175.
61. Herrmann H., Bar H., Kreplak L., Strelkov S.V., Aebi U. Intermediate filaments: from cell architecture to nanomechanics. Nature reviews. Mol. Cell Biol. 2007, 8:562-573.
62. Herrmann H., Strelkov S.V., Burkhard P., Aebi U. Intermediate filaments: primary determinants of cell architecture and plasticity. J. Clin. Invest. 2009, 119:1772-1783.
63. Hesse M., Franz T., Tamai Y., Taketo M.M., Magin T.M. Targeted deletion of keratins 18 and 19 leads to trophoblast fragility and early embryonic lethality. EMBO J. 2000, 19:5060-5070.
64. Hesse M., Magin T.M., Weber K. Genes for intermediate filament proteins and the draft sequence of the human genome: novel keratin genes and a surprisingly high number of pseudogenes related to keratin genes 8 and 18. J. Cell Sci. 2001, 114:2569-2575.
65. Hesse M., Zimek A., Weber K., Magin T.M. Comprehensive analysis of keratin gene clusters in humans and rodents. Eur. J. Cell Biol. 2004, 83:19-26.
66. Hickerson R.P., Smith F.J., Reeves R.E., Contag C.H., Leake D., Leachman S.A., Milstone L.M., McLean W.H., Kaspar R.L. Single-nucleotide-specific siRNA targeting in a dominant-negative skin model. J. Investig. Dermatol. 2008, 128:594-605.
67. Hofmann I., Franke W.W. Heterotypic interactions and filament assembly of type I and type II cytokeratins in vitro: viscometry and determinations of relative affinities. Eur. J. Cell Biol. 1997, 72:122-132.
68. Igyarto B.Z., Kaplan D.H. Antigen presentation by Langerhans cells. Curr. Opin. Immunol. 2013, 25:115-119.
69. Intong L.R., Murrell D.F. Inherited epidermolysis bullosa: new diagnostic criteria and classification. Clin. Dermatol. 2012, 30:70-77.
70. Jackson S.J., Zhang Z., Feng D., Flagg M., O'Loughlin E., Wang D., Stokes N., Fuchs E., Yi R. Rapid and widespread suppression of self-renewal by microRNA-203 during epidermal differentiation. Development 2013, 140:1882-1891.
71. Jones J.C., Hopkinson S.B., Goldfinger L.E. Structure and assembly of hemidesmosomes. Bioessays 1998, 20:488-494.
72. Jucker M., Walker L.C. Self-propagation of pathogenic protein aggregates in neurodegenerative diseases. Nature 2013, 501:45-51.
73. Kalluri R., Weinberg R.A. The basics of epithelial-mesenchymal transition. J. Clin. Invest. 2009, 119:1420-1428.
74. Karantza V. Keratins in health and cancer: more than mere epithelial cell markers. Oncogene 2011, 30:127-138.
75. Karashima T., Tsuruta D., Hamada T., Ishii N., Ono F., Hashikawa K., Ohyama B., Natsuaki Y., Fukuda S., Koga H., Sogame R., Nakama T., Dainichi T., Hashimoto T. Interaction of plectin and intermediate filaments. J. Dermatol. Sci. 2012, 66:44-50.
76. Kawasaki H., Nagao K., Kubo A., Hata T., Shimizu A., Mizuno H., Yamada T., Amagai M. Altered stratum corneum barrier and enhanced percutaneous immune responses in filaggrin-null mice. J. Allergy Clin. Immunol. 2012, 129:1538 e1536-1546 e1536.
77. Kerns M.L., DePianto D., Dinkova-Kostova A.T., Talalay P., Coulombe P.A. Reprogramming of keratin biosynthesis by sulforaphane restores skin integrity in epidermolysis bullosa simplex. Proc. Natl. Acad. Sci. U.S.A 2007, 104:14460-14465.
78. Kerns M., DePianto D., Yamamoto M., Coulombe P.A. Differential modulation of keratin expression by sulforaphane occurs via Nrf2-dependent and -independent pathways in skin epithelia. Mol. Biol. Cell 2010, 21:4068-4075.
79. Keyes W.M., Wu Y., Vogel H., Guo X., Lowe S.W., Mills A.A. p63 deficiency activates a program of cellular senescence and leads to accelerated aging. Genes Dev. 2005, 19:1986-1999.
80. Kim S., Wong P., Coulombe P.A. A keratin cytoskeletal protein regulates protein synthesis and epithelial cell growth. Nature 2006, 441:362-365.
81. Kimonis V., DiGiovanna J.J., Yang J.M., Doyle S.Z., Bale S.J., Compton J.G. A mutation in the V1 end domain of keratin 1 in non-epidermolytic palmar-plantar keratoderma. J. Investig. Dermatol. 1994, 103:764-769.
82. Kirfel J., Peters B., Grund C., Reifenberg K., Magin T.M. Ectopic expression of desmin in the epidermis of transgenic mice permits development of a normal epidermis. Differentiation 2002, 70:56-68.
83. Kitajima Y. Regulation and impairments of dynamic desmosome and corneodesmosome remodeling. Eur. J. Dermatol. (Epub ahead of print) 2013.
84. Klintworth G.K. The molecular genetics of the corneal dystrophies-current status. Front. Biosci. 2003, 8:d687-d713.
85. Koch P.J., de Viragh P.A., Scharer E., Bundman D., Longley M.A., Bickenbach J., Kawachi Y., Suga Y., Zhou Z., Huber M., Hohl D., Kartasova T., Jarnik M., Steven A.C., Roop D.R. Lessons from loricrin-deficient mice: compensatory mechanisms maintaining skin barrier function in the absence of a major cornified envelope protein. J. Cell Biol. 2000, 151:389-400.
86. Koga H., Tsuruta D., Ohyama B., Ishii N., Hamada T., Ohata C., Furumura M., Hashimoto T. Desmoglein 3, its pathogenecity and a possibility for therapeutic target in pemphigus vulgaris. Expert Opin. Ther. Targets 2013, 17:293-306.
87. Koster M.I., Roop D.R. Mechanisms regulating epithelial stratification. Annu. Rev. Cell Dev. Biol. 2007, 23:93-113.
88. Koster M.I., Kim S., Huang J., Williams T., Roop D.R. TAp63alpha induces AP-2gamma as an early event in epidermal morphogenesis. Dev. Biol. 2006, 289:253-261.
89. Kouklis P.D., Hutton E., Fuchs E. Making a connection: direct binding between keratin intermediate filaments and desmosomal proteins. J. Cell Biol. 1994, 127:1049-1060.
90. Kroger C., Vijayaraj P., Reuter U., Windoffer R., Simmons D., Heukamp L., Leube R., Magin T.M. Placental vasculogenesis is regulated by keratin-mediated hyperoxia in murine decidual tissues. Am. J. Pathol. 2011, 178:1578-1590.
91. Kroger C., Loschke F., Schwarz N., Windoffer R., Leube R.E., Magin T.M. Keratins control intercellular adhesion involving PKC-alpha-mediated desmoplakin phosphorylation. J. Cell Biol. 2013, 201:681-692.
92. Ku N.O., Omary M.B. A disease- and phosphorylation-related nonmechanical function for keratin 8. J. Cell Biol. 2006, 174:115-125.
93. Ku N.O., Michie S., Resurreccion E.Z., Broome R.L., Omary M.B. Keratin binding to 14-3-3 proteins modulates keratin filaments and hepatocyte mitotic progression. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:4373-4378.
94. Ku N.O., Toivola D.M., Strnad P., Omary M.B. Cytoskeletal keratin glycosylation protects epithelial tissue from injury. Nat. Cell Biol. 2010, 12:876-885.
95. Lane E.B., McLean W.H. Keratins and skin disorders. J. Pathol. 2004, 204:355-366.
96. Lane E.B., Rugg E.L., Navsaria H., Leigh I.M., Heagerty A.H., Ishida-Yamamoto A., Eady R.A. A mutation in the conserved helix termination peptide of keratin 5 in hereditary skin blistering. Nature 1992, 356:244-246.
97. Langbein L., Schweizer J. Keratins of the human hair follicle. Int. Rev. Cytol. 2005, 243:1-78.
98. Langbein L., Spring H., Rogers M.A., Praetzel S., Schweizer J. Hair keratins and hair follicle-specific epithelial keratins. Methods Cell Biol. 2004, 78:413-451.
99. Larouche D., Tong X., Fradette J., Coulombe P.A., Germain L. Vibrissa hair bulge houses two populations of skin epithelial stem cells distinct by their keratin profile. FASEB J. 2008, 22:1404-1415.
100. Lazarides E. Intermediate filaments as mechanical integrators of cellular space. Nature 1980, 283:249-256.
101. Lazarides E. Intermediate filaments: a chemically heterogeneous, developmentally regulated class of proteins. Annu. Rev. Biochem. 1982, 219-250.
102. Lee C.H., Coulombe P.A. Self-organization of keratin intermediate filaments into cross-linked networks. J. Cell Biol. 2009, 186:409-421.
103. Lee C.H., Kim M.S., Chung B.M., Leahy D.J., Coulombe P.A. Structural basis for heteromeric assembly and perinuclear organization of keratin filaments. Nat. Struct. Mol. Biol. 2012, 19:707-715.
104. Leers M.P., Kolgen W., Bjorklund V., Bergman T., Tribbick G., Persson B., Bjorklund P., Ramaekers F.C., Bjorklund B., Nap M., Jornvall H., Schutte B. Immunocytochemical detection and mapping of a cytokeratin 18 neo-epitope exposed during early apoptosis. J. Pathol. 1999, 187:567-572.
105. Lepinoux-Chambaud C., Eyer J. Review on intermediate filaments of the nervous system and their pathological alterations. Histochem. Cell Biol. 2013, 140:13-22.
106. Leslie Pedrioli D.M., Fu D.J., Gonzalez-Gonzalez E., Contag C.H., Kaspar R.L., Smith F.J., McLean W.H. Generic and personalized RNAi-based therapeutics for a dominant-negative epidermal fragility disorder. J. Investig. Dermatol. 2012, 132:1627-1635.
107. Lessard J.C., Coulombe P.A. Keratin 16-null mice develop palmoplantar keratoderma, a hallmark feature of pachyonychia congenita and related disorders. J. Investig. Dermatol. 2012, 132:1384-1391.
108. Lessard J.C., Pina-Paz S., Rotty J.D., Hickerson R.P., Kaspar R.L., Balmain A., Coulombe P.A. Keratin 16 regulates innate immunity in response to epidermal barrier breach. Proc. Natl. Acad. Sci. U.S.A 2013, 110:19537-19542.
109. Leube R.E., Moch M., Kolsch A., Windoffer R. "Panta rhei": perpetual cycling of the keratin cytoskeleton. Bioarchitecture 2011, 1:39-44.
110. Liovic M., D'Alessandro M., Tomic-Canic M., Bolshakov V.N., Coats S.E., Lane E.B. Severe keratin 5 and 14 mutations induce down-regulation of junction proteins in keratinocytes. Exp. Cell Res. 2009, 315:2995-3003.
111. Lloyd C., Yu Q.C., Cheng J., Turksen K., Degenstein L., Hutton E., Fuchs E. The basal keratin network of stratified squamous epithelia: defining K15 function in the absence of K14. J. Cell Biol. 1995, 129:1329-1344.
112. Loffek S., Woll S., Hohfeld J., Leube R.E., Has C., Bruckner-Tuderman L., Magin T.M. The ubiquitin ligase CHIP/STUB1 targets mutant keratins for degradation. Hum. Mutat. 2010, 31:466-476.
113. Lorand L., Graham R.M. Transglutaminases: crosslinking enzymes with pleiotropic functions. Nature reviews. Mol. Cell Biol. 2003, 4:140-156.
114. Lu H., Chen J., Planko L., Zigrino P., Klein-Hitpass L., Magin T.M. Induction of inflammatory cytokines by a keratin mutation and their repression by a small molecule in a mouse model for EBS. J. Investig. Dermatol. 2007, 127:2781-2789.
115. Lyle S., Christofidou-Solomidou M., Liu Y., Elder D.E., Albelda S., Cotsarelis G. The C8/144B monoclonal antibody recognizes cytokeratin 15 and defines the location of human hair follicle stem cells. J. Cell Sci. 1998, 111(Pt. 21):3179-3188.
116. Ma S., Rao L., Freedberg I.M., Blumenberg M. Transcriptional control of K5, K6, K14, and K17 keratin genes by AP-1 and NF-kappaB family members. Gene Expr. 1997, 6:361-370.
117. Magin T.M., Schroder R., Leitgeb S., Wanninger F., Zatloukal K., Grund C., Melton D.W. Lessons from keratin 18 knockout mice: formation of novel keratin filaments, secondary loss of keratin 7 and accumulation of liver-specific keratin 8-positive aggregates. J. Cell Biol. 1998, 140:1441-1451.
118. Magin T.M., Kaiser H.W., Leitgeb S., Grund C., Leigh I.M., Morley S.M., Lane E.B. Supplementation of a mutant keratin by stable expression of desmin in cultured human EBS keratinocytes. J. Cell Sci. 2000, 113(Pt. 23):4231-4239.
119. Margadant C., Frijns E., Wilhelmsen K., Sonnenberg A. Regulation of hemidesmosome disassembly by growth factor receptors. Curr. Opin. Cell Biol. 2008, 20:589-596.
120. Matsuki M., Yamashita F., Ishida-Yamamoto A., Yamada K., Kinoshita C., Fushiki S., Ueda E., Morishima Y., Tabata K., Yasuno H., Hashida M., Iizuka H., Ikawa M., Okabe M., Kondoh G., Kinoshita T., Takeda J., Yamanishi K. Defective stratum corneum and early neonatal death in mice lacking the gene for transglutaminase 1 (keratinocyte transglutaminase). Proc. Natl. Acad. Sci. U.S.A 1998, 95:1044-1049.
121. McLean W.H., Moore C.B. Keratin disorders: from gene to therapy. Hum. Mol. Genet. 2011, 20:R189-R197.
122. McLean W.H., Rugg E.L., Lunny D.P., Morley S.M., Lane E.B., Swensson O., Dopping-Hepenstal P.J., Griffiths W.A., Eady R.A., Higgins C., et al. Keratin 16 and keratin 17 mutations cause pachyonychia congenita. Nat. Genet. 1995, 9:273-278.
123. McLean W.H., Hansen C.D., Eliason M.J., Smith F.J. The phenotypic and molecular genetic features of pachyonychia congenita. J. Investig. Dermatol. 2011, 131:1015-1017.
124. Meng J.J., Bornslaeger E.A., Green K.J., Steinert P.M., Ip W. Two-hybrid analysis reveals fundamental differences in direct interactions between desmoplakin and cell type-specific intermediate filaments. J. Biol. Chem. 1997, 272:21495-21503.
125. Menon M.B., Schwermann J., Singh A.K., Franz-Wachtel M., Pabst O., Seidler U., Omary M.B., Kotlyarov A., Gaestel M. p38 MAP kinase and MAPKAP kinases MK2/3 cooperatively phosphorylate epithelial keratins. J. Biol. Chem. 2010, 285:33242-33251.
126. Middeldorp J., Hol E.M. GFAP in health and disease. Prog. Neurobiol. 2011, 93:421-443.
127. Moll I., Kuhn C., Moll R. Cytokeratin 20 is a general marker of cutaneous Merkel cells while certain neuronal proteins are absent. J. Investig. Dermatol. 1995, 104:910-915.
128. Moll R., Divo M., Langbein L. The human keratins: biology and pathology. Histochem. Cell Biol. 2008, 129:705-733.
129. Moorwood C. Syncoilin, an intermediate filament-like protein linked to the dystrophin associated protein complex in skeletal muscle. Cell. Mol. Life Sci. 2008, 65:2957-2963.
130. Mostowy S., Cossart P. Septins: the fourth component of the cytoskeleton. Nat. Rev. Mol. Cell Biol. 2012, 13:183-194.
131. Nanba D., Toki F., Barrandon Y., Higashiyama S. Recent advances in the epidermal growth factor receptor/ligand system biology on skin homeostasis and keratinocyte stem cell regulation. J. Dermatol. Sci. 2013, 72:81-86.
132. Nelson W.G., Sun T.T. The 50- and 58-kdalton keratin classes as molecular markers for stratified squamous epithelia: cell culture studies. J. Cell Biol. 1983, 97:244-251.
133. Nguyen B.C., Lefort K., Mandinova A., Antonini D., Devgan V., Della Gatta G., Koster M.I., Zhang Z., Wang J., Tommasi di Vignano A., Kitajewski J., Chiorino G., Roop D.R., Missero C., Dotto G.P. Cross-regulation between Notch and p63 in keratinocyte commitment to differentiation. Genes Dev. 2006, 20:1028-1042.
134. Niessen C.M. Tight junctions/adherens junctions: basic structure and function. J. Investig. Dermatol. 2007, 127:2525-2532.
135. Odaka C., Loranger A., Takizawa K., Ouellet M., Tremblay M.J., Murata S., Inoko A., Inagaki M., Marceau N. Keratin 8 is required for the maintenance of architectural structure in thymus epithelium. PLoS One 2013, 8:e75101.
136. Omary M.B. "IF-pathies": a broad spectrum of intermediate filament-associated diseases. J. Clin. Invest. 2009, 119:1756-1762.
137. Omary M.B., Ku N.O., Liao J., Price D. Keratin modifications and solubility properties in epithelial cells and in vitro. Subcell. Biochem. 1998, 31:105-140.
138. Omary M.B., Ku N.O., Tao G.Z., Toivola D.M., Liao J. "Heads and tails" of intermediate filament phosphorylation: multiple sites and functional insights. Trends Biochem. Sci. 2006, 31:383-394.
139. Omary M.B., Ku N.O., Strnad P., Hanada S. Toward unraveling the complexity of simple epithelial keratins in human disease. J. Clin. Invest. 2009, 119:1794-1805.
140. Osmanagic-Myers S., Gregor M., Walko G., Burgstaller G., Reipert S., Wiche G. Plectin-controlled keratin cytoarchitecture affects MAP kinases involved in cellular stress response and migration. J. Cell Biol. 2006, 174:557-568.
141. Pan X., Kane L.A., Van Eyk J.E., Coulombe P.A. Type I keratin 17 protein is phosphorylated on serine 44 by p90 ribosomal protein S6 kinase 1 (RSK1) in a growth- and stress-dependent fashion. J. Biol. Chem. 2011, 286:42403-42413.
142. Pan X., Hobbs R.P., Coulombe P.A. The expanding significance of keratin intermediate filaments in normal and diseased epithelia. Curr. Opin. Cell Biol. 2013, 25:47-56.
143. Paramio J.M., Segrelles C., Ruiz S., Jorcano J.L. Inhibition of protein kinase B (PKB) and PKCzeta mediates keratin K10-induced cell cycle arrest. Mol. Cell Biol. 2001, 21:7449-7459.
144. Parry D.A., Strelkov S.V., Burkhard P., Aebi U., Herrmann H. Towards a molecular description of intermediate filament structure and assembly. Exp. Cell Res. 2007, 313:2204-2216.
145. Peters B., Kirfel J., Bussow H., Vidal M., Magin T.M. Complete cytolysis and neonatal lethality in keratin 5 knockout mice reveal its fundamental role in skin integrity and in epidermolysis bullosa simplex. Mol. Biol. Cell 2001, 12:1775-1789.
146. Potten C.S., Morris R.J. Epithelial stem cells in vivo. J. Cell Sci. Suppl. 1988, 10:45-62.
147. Quigley D.A., To M.D., Perez-Losada J., Pelorosso F.G., Mao J.H., Nagase H., Ginzinger D.G., Balmain A. Genetic architecture of mouse skin inflammation and tumour susceptibility. Nature 2009, 458:505-508.
148. Ramms L., Fabris G., Windoffer R., Schwarz N., Springer R., Zhou C., Lazar J., Stiefel S., Hersch N., Schnakenberg U., Magin T.M., Leube R.E., Merkel R., Hoffmann B. Keratins as the main component for the mechanical integrity of keratinocytes. Proc. Natl. Acad. Sci. U.S.A 2013, 110:18513-18518.
149. Reichelt J., Magin T.M. Hyperproliferation, induction of c-Myc and 14-3-3sigma, but no cell fragility in keratin-10-null mice. J. Cell Sci. 2002, 115:2639-2650.
150. Reichelt J., Bussow H., Grund C., Magin T.M. Formation of a normal epidermis supported by increased stability of keratins 5 and 14 in keratin 10 null mice. Mol. Biol. Cell 2001, 12:1557-1568.
151. Reichelt J., Furstenberger G., Magin T.M. Loss of keratin 10 leads to mitogen-activated protein kinase (MAPK) activation, increased keratinocyte turnover, and decreased tumor formation in mice. J. Investig. Dermatol. 2004, 123:973-981.
152. Resing K.A., Dale B.A., Walsh K.A. Multiple copies of phosphorylated filaggrin in epidermal profilaggrin demonstrated by analysis of tryptic peptides. Biochemistry 1985, 24:4167-4175.
153. Resing K.A., Johnson R.S., Walsh K.A. Characterization of protease processing sites during conversion of rat profilaggrin to filaggrin. Biochemistry 1993, 32:10036-10045.
154. Rice R.H., Green H. The cornified envelope of terminally differentiated human epidermal keratinocytes consists of cross-linked protein. Cell 1977, 11:417-422.
155. Ridge K.M., Linz L., Flitney F.W., Kuczmarski E.R., Chou Y.H., Omary M.B., Sznajder J.I., Goldman R.D. Keratin 8 phosphorylation by protein kinase C delta regulates shear stress-mediated disassembly of keratin intermediate filaments in alveolar epithelial cells. J. Biol. Chem. 2005, 280:30400-30405.
156. Rogers M.A., Winter H., Langbein L., Bleiler R., Schweizer J. The human type I keratin gene family: characterization of new hair follicle specific members and evaluation of the chromosome 17q21.2 gene domain. Differentiation 2004, 72:527-540.
157. Rogers M.A., Edler L., Winter H., Langbein L., Beckmann I., Schweizer J. Characterization of new members of the human type II keratin gene family and a general evaluation of the keratin gene domain on chromosome 12q13.13. J. Investig. Dermatol. 2005, 124:536-544.
158. Roop D.R., Cheng C.K., Toftgard R., Stanley J.R., Steinert P.M., Yuspa S.H. The use of cDNA clones and monospecific antibodies as probes to monitor keratin gene expression. Ann. N. Y. Acad. Sci. 1985, 455:426-435.
159. Roth W., Reuter U., Wohlenberg C., Bruckner-Tuderman L., Magin T.M. Cytokines as genetic modifiers in K5-/- mice and in human epidermolysis bullosa simplex. Hum. Mutat. 2009, 30:832-841.
160. Roth W., Hatzfeld M., Friedrich M., Thiering S., Magin T.M. Keratin function and regulation in tissue homeostasis and pathogenesis. Biomol. Concepts 2012, 3. Band 3, Heft 2, 161-173.
161. Roth W., Hatzfeld M., Magin T.M. Targeting the palm: a leap forward toward treatment of keratin disorders. J. Investig. Dermatol. 2012, 132:1541-1542.
162. Roth W., Kumar V., Beer H.D., Richter M., Wohlenberg C., Reuter U., Thiering S., Staratschek-Jox A., Hofmann A., Kreusch F., Schultze J.L., Vogl T., Roth J., Reichelt J., Hausser I., Magin T.M. Keratin 1 maintains skin integrity and participates in an inflammatory network in skin through interleukin-18. J. Cell Sci. 2012, 125:5269-5279.
163. Rotty J.D., Coulombe P.A. A wound-induced keratin inhibits Src activity during keratinocyte migration and tissue repair. J. Cell Biol. 2012, 197:381-389.
164. Sawamura D., Nakano H., Matsuzaki Y. Overview of epidermolysis bullosa. J. Dermatol. 2010, 37:214-219.
165. Schutte B., Henfling M.E., Verheyen F.K., Li G., Tolstonog G.V., Ramaekers F.C. The caspase-9 derived C-terminal fragment of cytokeratin 18 modulates topoisomerase action. Int. J. Oncol. 2009, 35:625-630.
166. Schweizer J., Bowden P.E., Coulombe P.A., Langbein L., Lane E.B., Magin T.M., Maltais L., Omary M.B., Parry D.A., Rogers M.A., Wright M.W. New consensus nomenclature for mammalian keratins. J. Cell Biol. 2006, 174:169-174.
167. Sehgal B.U., DeBiase P.J., Matzno S., Chew T.L., Claiborne J.N., Hopkinson S.B., Russell A., Marinkovich M.P., Jones J.C. Integrin beta4 regulates migratory behavior of keratinocytes by determining laminin-332 organization. J. Biol. Chem. 2006, 281:35487-35498.
168. Seltmann K., Fritsch A.W., Kas J.A., Magin T.M. Keratins significantly contribute to cell stiffness and impact invasive behavior. Proc. Natl. Acad. Sci. U.S.A 2013, 110:18507-18512.
169. Seltmann K., Roth W., Kroger C., Loschke F., Lederer M., Huttelmaier S., Magin T.M. Keratins mediate localization of hemidesmosomes and repress cell motility. J. Investig. Dermatol. 2013, 133:181-190.
170. Sidhu G.S., Chandra P., Cassai N.D. Merkel cells, normal and neoplastic: an update. Ultrastruct. Pathol. 2005, 29:287-294.
171. Simon D.N., Wilson K.L. The nucleoskeleton as a genome-associated dynamic 'network of networks'. Nat. Rev. Mol. Cell Biol. 2011, 12:695-708.
172. Simpson C.L., Patel D.M., Green K.J. Deconstructing the skin: cytoarchitectural determinants of epidermal morphogenesis. Nat. Rev. Mol. Cell Biol. 2011, 12:565-580.
173. Sinha S., Degenstein L., Copenhaver C., Fuchs E. Defining the regulatory factors required for epidermal gene expression. Mol. Cell Biol. 2000, 20:2543-2555.
174. Snider N.T., Weerasinghe S.V., Iniguez-Lluhi J.A., Herrmann H., Omary M.B. Keratin hypersumoylation alters filament dynamics and is a marker for human liver disease and keratin mutation. J. Biol. Chem. 2011, 286:2273-2284.
175. Snider N.T., Leonard J.M., Kwan R., Griggs N.W., Rui L., Omary M.B. Glucose and SIRT2 reciprocally mediate the regulation of keratin 8 by lysine acetylation. J. Cell Biol. 2013, 200:241-247.
176. Snider N.T., Omary M.B. Post-translational modifications of intermediate filament proteins: mechanisms and functions. Nat. Rev. Mol. Cell Biol. 2014, 15(3):163-177.
177. Stappenbeck T.S., Green K.J. The desmoplakin carboxyl terminus coaligns with and specifically disrupts intermediate filament networks when expressed in cultured cells. J. Cell Biol. 1992, 116:1197-1209.
178. Stappenbeck T.S., Bornslaeger E.A., Corcoran C.M., Luu H.H., Virata M.L., Green K.J. Functional analysis of desmoplakin domains: specification of the interaction with keratin versus vimentin intermediate filament networks. J. Cell Biol. 1993, 123:691-705.
179. Stappenbeck T.S., Lamb J.A., Corcoran C.M., Green K.J. Phosphorylation of the desmoplakin COOH terminus negatively regulates its interaction with keratin intermediate filament networks. J. Biol. Chem. 1994, 269:29351-29354.
180. Steinert P.M. The two-chain coiled-coil molecule of native epidermal keratin intermediate filaments is a type I-type II heterodimer. J. Biol. Chem. 1990, 265:8766-8774.
181. Steinert P.M., Marekov L.N. The proteins elafin, filaggrin, keratin intermediate filaments, loricrin, and small proline-rich proteins 1 and 2 are isodipeptide cross-linked components of the human epidermal cornified cell envelope. J. Biol. Chem. 1995, 270:17702-17711.
182. Steinert P.M., Roop D.R. Molecular and cellular biology of intermediate filaments. Annu. Rev. Biochem. 1988, 57:593-625.
183. Steinert P.M., Jones J.C., Goldman R.D. Intermediate filaments. J. Cell Biol. 1984, 99:22s-27s.
184. Steinert P.M., Steven A.C., Roop D.R. The molecular biology of intermediate filaments. Cell 1985, 42:411-420.
185. Steinert P.M., Yang J.M., Bale S.J., Compton J.G. Concurrence between the molecular overlap regions in keratin intermediate filaments and the locations of keratin mutations in genodermatoses. Biochem. Biophys. Res. Commun. 1993, 197:840-848.
186. Terrinoni A., Serra V., Codispoti A., Talamonti E., Bui L., Palombo R., Sette M., Campione E., Didona B., Annicchiarico-Petruzzelli M., Zambruno G., Melino G., Candi E. Novel transglutaminase 1 mutations in patients affected by lamellar ichthyosis. Cell Death Dis. 2012, 3:e416.
187. Thiery J.P., Acloque H., Huang R.Y., Nieto M.A. Epithelial-mesenchymal transitions in development and disease. Cell 2009, 139:871-890.
188. Toivola D.M., Zhou Q., English L.S., Omary M.B. Type II keratins are phosphorylated on a unique motif during stress and mitosis in tissues and cultured cells. Mol. Biol. Cell 2002, 13:1857-1870.
189. Tong X., Coulombe P.A. Keratin 17 modulates hair follicle cycling in a TNFalpha-dependent fashion. Genes Dev. 2006, 20:1353-1364.
190. Tsuruta D., Hashimoto T., Hamill K.J., Jones J.C. Hemidesmosomes and focal contact proteins: functions and cross-talk in keratinocytes, bullous diseases and wound healing. J. Dermatol. Sci. 2011, 62:1-7.
191. Tumbar T., Guasch G., Greco V., Blanpain C., Lowry W.E., Rendl M., Fuchs E. Defining the epithelial stem cell niche in skin. Science (New York) 2004, 303:359-363.
192. Vasioukhin V., Bowers E., Bauer C., Degenstein L., Fuchs E. Desmoplakin is essential in epidermal sheet formation. Nat. Cell Biol. 2001, 3:1076-1085.
193. Vijayaraj P., Kroger C., Reuter U., Windoffer R., Leube R.E., Magin T.M. Keratins regulate protein biosynthesis through localization of GLUT1 and -3 upstream of AMP kinase and Raptor. J. Cell Biol. 2009, 187:175-184.
194. Vijayaraj P., Kroeger C., Reuter U., Hartmann D., Magin T.M. Keratins regulate yolk sac hematopoiesis and vasculogenesis through reduced BMP-4 signaling. Eur. J. Cell Biol. 2010, 89:299-306.
195. Wallace L., Roberts-Thompson L., Reichelt J. Deletion of K1/K10 does not impair epidermal stratification but affects desmosomal structure and nuclear integrity. J. Cell Sci. 2012, 125:1750-1758.
196. Watt F.M. Epidermal stem cells: markers, patterning and the control of stem cell fate. Philos. Trans. R. Soc. Lond. B Biol. Sci. 1998, 353:831-837.
197. Wertheim-Tysarowska K., Sota J., Kutkowska-Kazmierczak A., Wozniak K., Bal J., Kowalewski C. Coexistence of KRT14 and KRT5 mutations in polish patient with epidermolysis bullosa simplex. Br. J. Dermatol. 2014, 170:468-469.
198. Winter L., Wiche G. The many faces of plectin and plectinopathies: pathology and mechanisms. Acta Neuropathol. 2013, 125:77-93.
199. Wolf A., Rietscher K., Glass M., Huttelmaier S., Schutkowski M., Ihling C., Sinz A., Wingenfeld A., Mun A., Hatzfeld M. Insulin signaling via Akt2 switches plakophilin 1 function from stabilizing cell adhesion to promoting cell proliferation. J. Cell Sci. 2013, 126:1832-1844.
200. Wong P., Coulombe P.A. Loss of keratin 6 (K6) proteins reveals a function for intermediate filaments during wound repair. J. Cell Biol. 2003, 163:327-337.
201. Worman H.J. Nuclear lamins and laminopathies. J. Pathol. 2012, 226:316-325.
202. Yi R., Fuchs E. MicroRNA-mediated control in the skin. Cell Death Differ. 2010, 17:229-235.
203. Yi R., Poy M.N., Stoffel M., Fuchs E. A skin microRNA promotes differentiation by repressing 'stemness'. Nature 2008, 452:225-229.
204. Yuen W.Y., Sinke R.J., Jonkman M.F. ITGB4-associated non-Herlitz junctional epidermolysis bullosa: report of two new cases carrying two novel ITGB4 mutations. Br. J. Dermatol. 2013, 168:432-434.
205. Zhang H., Labouesse M. The making of hemidesmosome structures in vivo. Dev. Dyn. 2010, 239:1465-1476.
206. Zhang Y.Q., Sarge K.D. Sumoylation regulates lamin A function and is lost in lamin A mutants associated with familial cardiomyopathies. J. Cell Biol. 2008, 182:35-39.
207. Zhang H., Landmann F., Zahreddine H., Rodriguez D., Koch M., Labouesse M. A tension-induced mechanotransduction pathway promotes epithelial morphogenesis. Nature 2011, 471:99-103.
208. Zhao Y., Gartner U., Smith F.J., McLean W.H. Statins downregulate K6a promoter activity: a possible therapeutic avenue for pachyonychia congenita. J. Investig. Dermatol. 2011, 131:1045-1052.
209. Zhou Q., Cadrin M., Herrmann H., Chen C.H., Chalkley R.J., Burlingame A.L., Omary M.B. Keratin 20 serine 13 phosphorylation is a stress and intestinal goblet cell marker. J. Biol. Chem. 2006, 281:16453-16461.